Posted by Tomatheus on July 22, 2013, at 14:24:54
In reply to Re: Trending...'Misery Molecule', posted by brynb on July 22, 2013, at 13:39:21
Hi Bryn,
Thank you for your reply. Unfortunately, I'm not too familiar with the details of the trials being done on CFR1 antagonists, but I did know that the trials were being done. I can say that the drugs that I mentioned from the neurotransmitter.net site are in Phase II clinical development, which means that the drugs have made it through the earliest (Phase I) studies but are still in the process of being evaluated for efficacy and tolerability. That pretty much sums up what I know about the investigational medications that target the CRF1 receptor. Maybe somebody else here will know more about them.
T.
Conditions:
* chronic fatigue, hypersomnia, and related symptoms
* schizoaffective disordertomatheus.blogspot.com
poster:Tomatheus
thread:1047618
URL: http://www.dr-bob.org/babble/20130706/msgs/1047627.html